• Zum Hauptinhalt springen
  • Zum Footer springen
  • Deutsch - de
  • English - en

    SyNergy - Mu...

    • About
      • About us
      • Our Measures
      • Members
      • Cluster Management
      •  PhD & Postdoc representatives
      • Scientific Advisory Board
      •  International cooperation partners
      • Timeline
      •  Media Kit
      • Contact
    • News & Events
      • News
      • Events
      • In the News
      • Open Positions
    • Research
      • Publications
      • Our Research Focus
      • Technology Hubs
      • Research Spotlight
      • Research Data Management
      • Sustainability Initiative
      •  Code of Conduct
    • Science & Society
      • For Schools & Students
      • Public Events
      • Podcasts
      • Videos
    • Support for Diversity & Equity
      • Newcomer Center
      • Gender Equality Program
      • Early Career Investigator Program
    1. Home
    2. News & Events
    3. News
    4. Remyelination in the aged CNS activated by training the immune system 
    News | 12/08/2024 | Research Spotlight

    Remyelination in the aged CNS activated by training the immune system 

    The central nervous system's decreased ability to regenerate as we age limits its ability to recover after demyelinating injuries, such as MS lesions. Researchers have now discovered that through training the immune system inactive microglia can be reprogrammed, restoring their ability to repair neuronal lesions.

    This is a summary of V. Tiwari et al. (2024). Innate immune training restores pro-reparative myeloid functions to promote remyelination in the aged central nervous system as published in Immunity. https://doi.org/10.1016/j.immuni.2024.07.001


    The challenge

    Loss of myelin is typically associated with diseases where the immune system mistakenly attacks the myelin, as seen in multiple sclerosis (MS). The good news is that lost myelin can be regenerated (remyelination). However, the capacity to remyelinate MS lesions declines significantly with age. Previous research has demonstrated that an excess of myelin debris can hinder the ability of microglia to support tissue regeneration in aging. However, the specific mechanisms causing this are not well understood. Our study, therefore, aimed to investigate whether age-related changes in epigenetics play a role in reducing the responsiveness and reparative functions of microglia in demyelinating lesions. We also explored the possibility of using innate immune training to epigenetically reprogram and invigorate microglial responses, with the goal of reinstating reparative inflammation.


    Our approach

    We used mouse models to model and study the demyelination process. Furthermore, we used Bacillus Calmette-Guerin (BCG), a live-attenuated vaccine strain of Mycobacterium bovis, to train the innate immune system in a mouse model.


    Our findings

    Our mouse model showed that a substantial number of genes were not effectively activated in aged myeloid cells and that these genes displayed epigenetic modifications that are associated with restricted chromatin accessibility. We showed that epigenetic alterations, in particular histone acetylation levels, contribute to the poor responsiveness of microglia and, therefore, limit the responses in case of injury. Subsequently, removal of two class I histone deacetylases (HDAC1 and HDCA2) – which reversibly regulate the acetylation status of histones – in microglia restored the aged mice's ability to remyelinate damaged tissue. Furthermore, after training the immune system, we observed epigenetic reprogramming of brain-resident myeloid cells and functional restoration of myelin debris clearance and lesion recovery.


    The implications

    Our results suggest that aging leads to loss of microglial plasticity, causing the microglia to lose their capacity to mount a finely tuned response to injury. Our research implies that immune training may provide strategy for future therapeutic avenues.


    Creating SyNergies

    The research was led by Mikael Simons und included SyNergy members Martin Dichgans and Ozgun Gokce.

    Participating Universities
     LMU logo in white
     TUM logo in white
    Partner Institutions
     Logo DZNE in white
    Helmholtz Munich logo in white 
     Logo Max Planck Gesellschaft 

    SyNergy is funded by the Deutsche Forschungsgemeinschaft (German Research Foundation) within the framework of the German Excellence Strategy (EXC 2145 SyNergy – ID 390857198). The Excellence Strategy promotes outstanding research at German universities. 

    Contact

    Munich Cluster for Systems Neurology (SyNergy)

    Feodor-Lynen-Str. 17
    81377 Munich
    +49 (0)89 4400-46497
    yJüubgaybcјuipxј_vfulyzsmi
    Editor login
    Imprint | Data-Safety